Telephone
61.8.62850083
Address
Suite 3 41–47 Colin Street West Perth, Western Australia (WA) 6005
Description
Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. It operates through the Australia and the United States geographical segments. The company was founded by Matthew Callahan, Roger New, and Glen Travers in 1984 and is headquartered in West Perth, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.1 - 0.54
Trade Value (12mth)
AU$719,815.00
1 week
-3.03%
1 month
45.45%
YTD
-64.44%
1 year
-58.44%
All time high
163.33
EPS 3 yr Growth
246.70%
EBITDA Margin
%
Operating Cashflow
-$79m
Free Cash Flow Return
-73.80%
ROIC
-81.20%
Interest Coverage
-15.00
Quick Ratio
2.90
Shares on Issue (Fully Dilluted)
1861m
HALO Sector
Healthcare
Next Company Report Date
28-Aug-26
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.24
Date | Announcements |
---|---|
09 October 25 |
Change of Director's Interest Notice - V. Ippolito
×
Change of Director's Interest Notice - V. Ippolito |
08 October 25 |
Application for quotation of securities - BOT
×
Application for quotation of securities - BOT |
29 September 25 |
Change in substantial holding
×
Change in substantial holding |
08 September 25 |
Botanix to Present at HC Wainwright Investment Conference
×
Botanix to Present at HC Wainwright Investment Conference |
05 September 25 |
Botanix Announces Korean Regulatory Approval of ECCLOCK
×
Botanix Announces Korean Regulatory Approval of ECCLOCK |
03 September 25 |
Application for quotation of securities - BOT
×
Application for quotation of securities - BOT |
03 September 25 |
Section 708A(5)(e) Notice
×
Section 708A(5)(e) Notice |
29 August 25 |
2025 Annual General Meeting - Key Dates
×
2025 Annual General Meeting - Key Dates |
29 August 25 |
Appendix 4E & Annual Report for the Year Ended 30 June 2025
×
Appendix 4E & Annual Report for the Year Ended 30 June 2025 |
29 August 25 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
25 August 25 |
Botanix Appoints Dr Patricia Walker to the Board
×
Botanix Appoints Dr Patricia Walker to the Board |
25 August 25 |
Initial Director's Interest Notice - Dr Patricia Walker
×
Initial Director's Interest Notice - Dr Patricia Walker |
22 August 25 |
Notification regarding unquoted securities - BOT
×
Notification regarding unquoted securities - BOT |
12 August 25 |
Canaccord Genuity 45th Annual Growth Conference Presentation
×
Canaccord Genuity 45th Annual Growth Conference Presentation |
01 August 25 |
Notification of cessation of securities - BOT
×
Notification of cessation of securities - BOT |
31 July 25 |
Response to ASX Aware Letter
×
Response to ASX Aware Letter |
28 July 25 |
June 2025 Quarterly Activities Report and Appendix 4C
×
June 2025 Quarterly Activities Report and Appendix 4C |
24 July 25 |
Botanix Webinar - Monday 28 July - Registration Information
×
Botanix Webinar - Monday 28 July - Registration Information |
09 July 25 |
Botanix Sofdra Launch Update Presentation - Correction
×
Botanix Sofdra Launch Update Presentation - Correction |
08 July 25 |
Botanix Provides Sofdra Launch Update
×
Botanix Provides Sofdra Launch Update |
08 July 25 |
Sofdra Launch Update Investor Webinar
×
Sofdra Launch Update Investor Webinar |
04 July 25 |
Botanix Webinar Tuesday 8 July 2025 Registration Information
×
Botanix Webinar Tuesday 8 July 2025 Registration Information |
30 June 25 |
Application for quotation of securities - BOT
×
Application for quotation of securities - BOT |
30 June 25 |
Notification of cessation of securities - BOT
×
Notification of cessation of securities - BOT |
27 June 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.